Alehagen U - Search Results

1

Chromogranin A as a biomarker in cardiovascular disease.

Goetze JP, Alehagen U, Flyvbjerg A, Rehfeld JF. Goetze JP, et al. Among authors: alehagen u. Biomark Med. 2014;8(1):133-40. doi: 10.2217/bmm.13.102. Biomark Med. 2014. PMID: 24325234 Review.

2

Making sense of chromogranin A in heart disease.

Goetze JP, Alehagen U, Flyvbjerg A, Rehfeld JF. Goetze JP, et al. Among authors: alehagen u. Lancet Diabetes Endocrinol. 2013 Sep;1(1):7-8. doi: 10.1016/S2213-8587(13)70035-4. Epub 2013 Jun 13. Lancet Diabetes Endocrinol. 2013. PMID: 24622255 Review. No abstract available.

3

Cholecystokinin in plasma predicts cardiovascular mortality in elderly females.

Goetze JP, Rehfeld JF, Alehagen U. Goetze JP, et al. Among authors: alehagen u. Int J Cardiol. 2016 Apr 15;209:37-41. doi: 10.1016/j.ijcard.2016.02.038. Epub 2016 Feb 3. Int J Cardiol. 2016. PMID: 26878472

4

Impact of epitope specificity and precursor maturation in pro-B-type natriuretic peptide measurement.

Goetze JP, Dahlström U, Rehfeld JF, Alehagen U. Goetze JP, et al. Among authors: alehagen u. Clin Chem. 2008 Nov;54(11):1780-7. doi: 10.1373/clinchem.2008.105635. Epub 2008 Sep 11. Clin Chem. 2008. PMID: 18787017

5

N-terminal pro-atrial natriuretic peptide measurement in plasma suggests covalent modification.

Hunter I, Alehagen U, Dahlström U, Rehfeld JF, Crimmins DL, Goetze JP. Hunter I, et al. Among authors: alehagen u. Clin Chem. 2011 Sep;57(9):1327-30. doi: 10.1373/clinchem.2011.166330. Epub 2011 Jun 29. Clin Chem. 2011. PMID: 21715695

6

Plasma chromogranin A is a marker of death in elderly patients presenting with symptoms of heart failure.

Goetze JP, Hilsted LM, Rehfeld JF, Alehagen U. Goetze JP, et al. Among authors: alehagen u. Endocr Connect. 2014 Mar 11;3(1):47-56. doi: 10.1530/EC-14-0017. Print 2014. Endocr Connect. 2014. PMID: 24532383 Free PMC article.

7

Association of copeptin and N-terminal proBNP concentrations with risk of cardiovascular death in older patients with symptoms of heart failure.

Alehagen U, Dahlström U, Rehfeld JF, Goetze JP. Alehagen U, et al. JAMA. 2011 May 25;305(20):2088-95. doi: 10.1001/jama.2011.666. JAMA. 2011. PMID: 21610241

8

Effect of estimated glomerular filtration rate on plasma concentrations of B-type natriuretic peptides measured with multiple immunoassays in elderly individuals.

Schou M, Alehagen U, Goetze JP, Gustafsson F, Dahlstrom U. Schou M, et al. Among authors: alehagen u. Heart. 2009 Sep;95(18):1514-9. doi: 10.1136/hrt.2009.173666. Epub 2009 Jun 30. Heart. 2009. PMID: 19570761

9

Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements.

Alehagen U, Dahlström U, Rehfeld JF, Goetze JP. Alehagen U, et al. Clin Chem. 2010 Nov;56(11):1718-24. doi: 10.1373/clinchem.2009.141341. Epub 2010 Sep 15. Clin Chem. 2010. PMID: 20844063

10

Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.

Alehagen U, Dahlström U, Rehfeld JF, Goetze JP. Alehagen U, et al. J Card Fail. 2013 Jan;19(1):31-9. doi: 10.1016/j.cardfail.2012.11.002. J Card Fail. 2013. PMID: 23273592

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

123 results

Search Page